Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer

OBJECTIVE: Ovarian cancer is a highly lethal disease in which the majority of patients eventually demonstrate multidrug resistance. Develop a novel active targeted theranostic nanomedicine designed to overcome drug efflux mechanisms, using a Generally Regarded As Safe (GRAS) grade nanoemulsion (NE)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Deliv
Main Authors: Ganta, Srinivas, Singh, Amit, Rawal, Yashesh, Cacaccio, Joseph, Patel, Niravkumar R., Kulkarni, Praveen, Ferris, Craig F., Amiji, Mansoor M., Coleman, Timothy P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4380874/
https://ncbi.nlm.nih.gov/pubmed/24901206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10717544.2014.923068
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados